This aligns with our findings that NFKB-related gene sets are enriched in advanced-stage, aggressive bladder tumors and regulate UPR by suppressing miR-29b/c expression ((Figure 5; Supplementary Figures S4–S6). This evidence concerns the gene NFKB1 and urinary bladder neoplasm.